Page 40 - Sanket Koul

Mankind Pharma open to acquisitions; board okays Rs 7,500 cr fundraise

The drug maker was reportedly interested in buying private equity (PE) firm Advent International's stake in Mumbai-based biopharma firm Bharat Serums and Vaccines (BSV)

India set to cross 1800 MW in data centre capacity by 2026: CBRE report

Report adds that India has highest DC capacity among major APAC countries, likely to add another 850 MW in next 2 years

Mankind Pharma Q4 results: Net profit up by 62%, revenue rises by 18.9%

Mankind's revenue from operations rose to Rs 2,441 crore in Q4 FY24, an 18.9 per cent Y-o-Y rise from Rs 2,052 crore reported in Q4 FY23

PE firm ChrysCapital to invest up to Rs 830 crore in Centre For Sight

"This investment will support CFS's ability to further scale and serve the growing demand for eye care in India both across Tier-I and Tier-II cities," the statement added

Indian senior living market has potential to touch $12 bn by 2030: Report

Rise in median age and ageing population to fuel increase in demand for senior housing

AstraZeneca to withdraw Covid-19 vaccine Vaxzevria globally on weak demand

AstraZeneca will start the withdrawal of marketing authorisation for the vaccine in Europe

Abbott India Q4 results: Profit rises 24% to Rs 287 cr, revenue up 7%

The drugmaker's revenue from operations increased to Rs 1,439 crore, a 7 per cent increase from the Rs 1,343 crore recorded in Q4 FY23

Omron's India arm, AliveCor to market AI-based portable ECG in India

While stroke risk is 3.4 times higher with hypertension, it becomes nearly five times higher with Afib, which means that people who frequently experience Afib could face a stroke shortly

Birla Fertility acquires Kerala-based AMRC IVF to foray into South India

According to industry sources, the deal is valued at below Rs 100 crore, and the transaction will be financed through internal accruals

KKR acquires Bengaluru-based medical devices company Healthium MedTech

According to sources close to the deal, the value of the acquisition is Rs 6,500-7,000 crore

Quadria Capital picks up minority stake in NephroPlus for Rs 850 crore

Founded in 2010, NephroPlus currently operates about 450 dialysis centres across three main countries: India, the Philippines, and Uzbekistan

Number of medical tourists in India to exceed pre-pandemic levels in CY24

Major hospital chains in India are eyeing the rise in international patient revenue and exploring entry into new geographies

Spice controversy: Norms for pesticide residue stringent, says govt

In India, pesticides are regulated by the Ministry of Agriculture and Farmers Welfare through the Central Insecticide Board and Registration Committee (CIB & RC)

Abbott launches XIENCE Sierra coronary stent system for heart patients

The XIENCE Sierra is the latest generation of the XIENCE family of everolimus-eluting coronary stent systems

Manipal Hospitals plans to add 1,100 beds on top of already existing 10,500

Dilip Jose, MD & CEO of Manipal Hospitals tells Sanket Koul about the hospital chain's expansion plans and whether the company is looking to go for an initial public offering (IPO)

Healthcare industry announces support for talks on standardising rates

Many industry bodies too had become party to the case, urging the apex court to listen to their grievances as well

Manipal Hospitals to take 87% stake in Medica Synergie for Rs 1.4K crore

Deal will make it India's largest hospital chain with over 10,500 beds

Centre calls for broad consultations to standardise rates for hospitals

The Centre's affidavit also emphasised that fixation of rates may lead to serious issues like rendering healthcare setups financially unviable, and many other players may jack up the prices

Paras Health plans to operate upwards of 2,300 beds in North India by FY25

With this, Paras Health is aiming to operate upwards of 2,300 beds in North India by the end of FY 2025

Govt expands committee for drugs, medical devices pricing reforms

According to an industry source, the committee will also look at ways to design a price moderation framework for medical devices while providing incentives to the medtech industry to minimize imports